title: Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic.
abstract: The 2014 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV cure research. Combined anti-retroviral therapy (c-ART) has had a profound impact on the disease prognosis and transformed this infection into a chronic disease. However, HIV is able to persist within the infected host and the pandemic is still growing. The main 2014 ISHEID theme was, hence "Together for a world without HIV and AIDS". In this report we not only give details on this main topic but also summarize what has been discussed in the areas of HCV coinfection and present a short summary on currently emerging viral diseases.
authors.affiliation: Department of Infectious Diseases, General Hospital, Toulon, France.
authors.forename: Alain
authors.initials: A
authors.lastname: Lafeuillade
authors.affiliation: McGill University, Montreal, Canada.
authors.forename: Mark
authors.initials: M
authors.lastname: Wainberg
authors.affiliation: Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Pasteur Institute, Paris, France.
authors.forename: Marie-Lise
authors.initials: ML
authors.lastname: Gougeon
authors.affiliation: Royal Free Center for HIV Medicine, Department of Infection and Immunity, Royal Free Hospital, London, UK.
authors.forename: Sabine Kinloch-de
authors.initials: SK
authors.lastname: Loes
authors.affiliation: Internal Medicine and Infectious Diseases Department, European Hospital and Alphabio Laboratory, Marseille, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Halfon
authors.affiliation: Health Department, Research Institute for Development, Marseille, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Tissot-Dupont
keywords: Antiretroviral drugs; HCV; HIV; HIV cure; HIV reservoirs; HIV vaccine; Hepatitis E